Abstract
The human ras genes (Nras, Hras, and Kras) code for closely related small GTPases possessing a molecular size of about 21 KDa. Ras proteins operate as molecular switches in signal transduction cascades controlling cell proliferation, differentiation or apoptosis. As for all G proteins, the function of the ras gene protein products is controlled through a regulated GDP / GTP cycle. Each of the three human ras proto-oncogenes can give rise to a transforming oncogene via single base pair mutations. Mutations at codons 12, 13 or 61 significantly downgrade the GTPase ability of the resulting mutant Ras proteins, which are thus rendered constitutively active and able to transform mammalian cells. Indeed, the detection of such mutations in various human tumors indicates that deregulated GTP binding to Ras is involved in the development of up 30% of all human cancers. Specific members of the Ras family are mutated in different tumor types, with mutations in Kras appearing most frequently. Some tumor cell lines harbor amplified ras genes and transfection studies have shown that a 20-fold increase in the level of expressed normal Ras protein is sufficient to induce transformation of some recipient cells. Studies with knockout mice strains have revealed that Kras (but not Nras or Hras) is necessary and sufficient for the development of the animals to the adult stage. It remains unclear whether the different Ras family members play totally specific or overlapping functional roles in the cell. Recent data on localization to different plasma membrane subdomains, marked quantitative differences of effector activation levels and new roles for some docking / scaffold proteins point to signaling specificities of the different Ras proteins. This review analyzes the current understanding of Ras function focusing on the possible physiological and oncogenic specificities of each Ras family member.
Keywords: ras gene, nras,hras,kras, ras protein, photo-oncogene
Current Genomics
Title: ras Genes and Human Cancer: Different Implications and Different Roles
Volume: 3 Issue: 4
Author(s): Jose M. Rojas and Eugenio Santos
Affiliation:
Keywords: ras gene, nras,hras,kras, ras protein, photo-oncogene
Abstract: The human ras genes (Nras, Hras, and Kras) code for closely related small GTPases possessing a molecular size of about 21 KDa. Ras proteins operate as molecular switches in signal transduction cascades controlling cell proliferation, differentiation or apoptosis. As for all G proteins, the function of the ras gene protein products is controlled through a regulated GDP / GTP cycle. Each of the three human ras proto-oncogenes can give rise to a transforming oncogene via single base pair mutations. Mutations at codons 12, 13 or 61 significantly downgrade the GTPase ability of the resulting mutant Ras proteins, which are thus rendered constitutively active and able to transform mammalian cells. Indeed, the detection of such mutations in various human tumors indicates that deregulated GTP binding to Ras is involved in the development of up 30% of all human cancers. Specific members of the Ras family are mutated in different tumor types, with mutations in Kras appearing most frequently. Some tumor cell lines harbor amplified ras genes and transfection studies have shown that a 20-fold increase in the level of expressed normal Ras protein is sufficient to induce transformation of some recipient cells. Studies with knockout mice strains have revealed that Kras (but not Nras or Hras) is necessary and sufficient for the development of the animals to the adult stage. It remains unclear whether the different Ras family members play totally specific or overlapping functional roles in the cell. Recent data on localization to different plasma membrane subdomains, marked quantitative differences of effector activation levels and new roles for some docking / scaffold proteins point to signaling specificities of the different Ras proteins. This review analyzes the current understanding of Ras function focusing on the possible physiological and oncogenic specificities of each Ras family member.
Export Options
About this article
Cite this article as:
Rojas M. Jose and Santos Eugenio, ras Genes and Human Cancer: Different Implications and Different Roles, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350381
DOI https://dx.doi.org/10.2174/1389202023350381 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Gene Expression Under the Influence: Transcriptional Profiling of Ethanol in the Brain
Current Psychopharmacology A Genome-Wide Identification and Analysis of the Basic Helix-Loop-Helix Transcription Factors in Water Buffalo (Bubalus bubalis)
Current Proteomics Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Current Medicinal Chemistry - Anti-Cancer Agents Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Current Gene Therapy VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets Experimental Models of Discovery: Prediction and Protection must Proceed “Hand-in-Hand”
Current Neurovascular Research Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Acetylcholinesterase Inhibitor Donepezil Effects on Plasma β-Hydroxybutyrate Levels in the Treatment of Alzheimer’s Disease
Current Alzheimer Research Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
Current Pharmaceutical Design Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Current Cancer Drug Targets Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues
Current Pharmaceutical Design New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Current Pharmaceutical Design Recent Syntheses and Biological Activity of Lentiginosine and its Analogues
Current Topics in Medicinal Chemistry Effects of Smokeless Tobacco Samples from Tabuk Saudi Arabia on Nitric Oxide Production: A Potential Risk for Cancer and Cardiovascular Diseases
Current Computer-Aided Drug Design Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats
Current Alzheimer Research Review on Documented Medicinal Plants used for the Treatment of Cancer
Current Traditional Medicine